Stefan Michiels

Active 2003–2025

154
Papers
27,881
Citations
84
h-index
146
i10-index

Citations

Citations per year for Stefan Michiels1986: 1 citations1987: 1 citations1999: 2 citations2003: 3 citations2004: 2 citations2005: 30 citations2006: 69 citations2007: 88 citations2008: 104 citations2009: 93 citations2010: 125 citations2011: 91 citations2012: 130 citations2013: 142 citations2014: 209 citations2015: 268 citations2016: 298 citations2017: 325 citations2018: 333 citations2019: 1,001 citations2020: 1,331 citations2021: 1,420 citations2022: 1,206 citations2023: 937 citations2024: 1,453 citations2025: 762 citations2026: 43 citations1988–1998: no citations, so these years are not shown2000–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,919 citing papers, 20% of this breakdownChina: 1,426 citing papers, 9.8% of this breakdownFrance: 991 citing papers, 6.8% of this breakdownItaly: 986 citing papers, 6.8% of this breakdownUnited Kingdom: 834 citing papers, 5.7% of this breakdownGermany: 810 citing papers, 5.5% of this breakdownSpain: 534 citing papers, 3.7% of this breakdownBelgium: 489 citing papers, 3.3% of this breakdownAustralia: 471 citing papers, 3.2% of this breakdownNetherlands: 450 citing papers, 3.1% of this breakdownCanada: 408 citing papers, 2.8% of this breakdownJapan: 405 citing papers, 2.8% of this breakdown
0%20%Other 26.5%

Fields

  • Medicine56.1%
  • Biochemistry, Genetics and Molecular Biology32.1%
  • Immunology and Microbiology5%
  • Computer Science2.8%
  • Mathematics1%
  • Engineering0.7%
  • Other2.3%

Topics

  • Cancer Immunotherapy and Biomarkers8.7%
  • Cancer Genomics and Diagnostics6.4%
  • Breast Cancer Treatment Studies4.4%
  • Cancer Cells and Metastasis4.1%
  • Immunotherapy and Immune Responses3.8%
  • Lung Cancer Treatments and Mutations2.7%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 1,188

  2. CD4+ follicular helper T cell infiltration predicts breast cancer survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 1,050

  3. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 891

  4. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  5. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 1,647

  6. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Fabrice André, Jean‐Charles Soria - Cancer Discovery 2017 cited by 776

  7. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2024 cited by 345

  8. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    Authors: , , , , , , , , , , , , , , , - Annals of Oncology 2014 cited by 1,270

  9. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista and 454 more - npj Breast Cancer 2021 cited by 275

  10. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  11. Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 464

  12. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition

    Authors: , , , , , , - Annals of Oncology 2021 cited by 271

  13. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich‐Franz Solomayer, Laura Zorzino, Helene Johannes, Jorge S. Reis‐Filho, Klaus Pantel, Jean‐Yves Pierga, Stefan Michiels - The Lancet Oncology 2014 cited by 838

  14. Biomarker Discovery and Validation: Statistical Considerations

    Authors: , , , , - Journal of Thoracic Oncology 2021 cited by 232

  15. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Matthew P. Goetz, Stefan Michiels, International Immuno-Oncology Biomarker Working Group - JAMA 2024 cited by 199

  16. Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab

    Authors: , , , , , , , , , , , , , , - JAMA Oncology 2015 cited by 606

  17. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Seminars in Cancer Biology 2017 cited by 432

  18. Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges

    Authors: , , , , , , , , , , , - BMC Medicine 2023 cited by 88

  19. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paolo Nucíforo, Rodrigo Dienstmann, Chandra Verma, Núria López-Bigas, Maurizio Scaltriti, Mónica Arnedos, Cristina Saura, Violeta Serra - Nature Communications 2022 cited by 120

  20. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo and 156 more - npj Breast Cancer 2020 cited by 206

  21. Resistance to Selective FGFR Inhibitors in FGFR- Driven Urothelial Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 cited by 76

  22. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 cited by 282

  23. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul J. van Diest, Marjanka K. Schmidt, Marleen Kok, Gwen M.H.E. Dackus, Roberto Salgado, Sabine C. Linn - Journal of Clinical Oncology 2022 cited by 144

  24. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. J. van Diest - 2022 cited by 103